SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-261293
Filing Date
2020-10-01
Accepted
2020-10-01 16:05:56
Documents
15
Period of Report
2020-10-01
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d153950d8k.htm   iXBRL 8-K 38527
2 EX-3.1 d153950dex31.htm EX-3.1 9895
3 EX-99.1 d153950dex991.htm EX-99.1 11440
7 GRAPHIC g153950g1001071216272.jpg GRAPHIC 3407
  Complete submission text file 0001193125-20-261293.txt   202342

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA adro-20201001.xsd EX-101.SCH 3094
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE adro-20201001_lab.xml EX-101.LAB 18874
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adro-20201001_pre.xml EX-101.PRE 11873
8 EXTRACTED XBRL INSTANCE DOCUMENT d153950d8k_htm.xml XML 3551
Mailing Address 740 HEINZ AVENUE BERKELEY CA 94710
Business Address 740 HEINZ AVENUE BERKELEY CA 94710 510-848-4400
ADURO BIOTECH, INC. (Filer) CIK: 0001435049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37345 | Film No.: 201215929
SIC: 2834 Pharmaceutical Preparations